Know your neighbors: Different tumor microenvironments have implications in immunotherapeutic targeting strategies across MB subgroups

Abstract

Medulloblastoma (MB) is the most common pediatric brain tumor with few reports of successful immunologic targeting. We have recently demonstrated the immune tumor microenvironment as well as response to immune checkpoint blockade differ across subtypes of murine MB.